“Assessment of YME1L and mitofusin2 as a possible diagnostic and/or therapeutic target in hepatocellular carcinoma”, IJBB, vol. 60, no. 1, pp. 43–54, Jun. 2023, doi: 10.56042/ijbb.v60i1.62503.